Dr. Brian Milton Isler, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1025 Refugee Rd Ste 100a, Pickerington, OH 43147 Phone: 614-754-5500 Fax: 614-754-5501 |
Dr. Dhairya Dipen Mehta, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1025 Refugee Rd Ste 100a, Pickerington, OH 43147 Phone: 614-754-5500 Fax: 614-457-9519 |
Ahmad Nasr Anaizi, MD Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1025 Refugee Rd Fl 1, Pickerington, OH 43147 Phone: 614-754-5500 Fax: 614-754-5501 |
Dr. Seth David Hoffman, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1025 Refugee Rd Ste 100a, Pickerington, OH 43147 Phone: 614-754-5500 Fax: 614-754-5501 |
News Archive
Prostate cancer is the most common cancer among males in the United States. Approximately, 180,000 men are diagnosed each year, and approximately 95 percent of these men have localized disease that is potentially curable.
A study led by the Hasbro Children's Hospital Division of Pediatric Gastroenterology, Nutrition and Liver Diseases found that the incidence of inflammatory bowel disease (IBD) in Rhode Island is one of the highest ever reported in the United States and that IBD rates nationally are much higher than previously reported.
A free source of evidence-based information for health care professionals and for researchers studying liver injury associated with prescription and over-the-counter drugs, herbals, and dietary supplements is now available from the National Institutes of Health. Researchers and health care professionals can use the LiverTox database to identify basic and clinical research questions to be answered and to chart optimal ways to diagnose and control drug-induced liver injury.
Naviscan announced today that Alliance Imaging, a division of Alliance Healthcare Services, will be offering mobile Positron Emission Mammography imaging services in the state of Florida. Alliance Imaging will be providing turnkey service which includes transporting the PEM scanner from site to site, a technologist to perform the scan and the necessary radiopharmaceutical, 18F-FDG.
Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent Office (USPTO) has allowed a patent (Application No. 10/560,336) for the Woppmann et al. patent series, entitled "Double-stranded ribonucleic acid with increased effectiveness in an organism." The newly allowed patent includes 31 claims broadly covering compositions and methods, including pharmaceutical compositions, for small interfering RNAs (siRNAs), the molecules that mediate RNAi.
› Verified 5 days ago